MicrobiologyThe Lancet Infectious DiseasesPeer-reviewed
Robust antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against a broad range of SARS-CoV-2 Omicron subvariants including JN.1, KP.3.1.1 and XEC
Keiya Uriu, Yu Kaku, Yoshifumi Uwamino…·Kei Sato
This study compares the antiviral humoral immunity induced by two JN.1 monovalent mRNA vaccines against multiple SARS-CoV-2 Omicron subvariants and XEC, showing both vaccines boost immunity with statistical significance.
25 citationstop 2%